What Researchers Did
Researchers conducted a retrospective case series to evaluate the utility of hyperbaric oxygen therapy (HBOT) in five patients experiencing recurrent acute bowel obstruction following previous pelvic radiotherapy.
What They Found
Five patients (median age 56) with recurrent acute bowel obstruction after pelvic radiotherapy received hyperbaric oxygen therapy (HBOT). Before HBOT, symptoms occurred at 1-6 weekly intervals, and all patients received 40 sessions, with three requiring an additional 20 sessions for complete resolution of symptoms. HBOT was well tolerated with no side effects.
What This Means for Canadian Patients
Canadian patients experiencing recurrent acute bowel obstruction after pelvic radiotherapy might find hyperbaric oxygen therapy (HBOT) to be a beneficial treatment option. This could offer relief from debilitating symptoms and improve their quality of life.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study's main limitation is its retrospective case series design with only five patients, limiting the generalizability of the findings.